DW

David Williams

Arovella Therapeutics Limited | Non-Executive Director, Non-Executive Chairman
Mr Williams is experienced director and corporate advisor with career spanning over four decades advising a wide range of ASX listed companies. He has deep expertise in business development, mergers and acquisitions, and capital. He is currently the Chairman of Arovella Therapeutics ASX: ALA and the corporate advisory firm Kidder Williams Ltd.

Companies and Roles

Company
Title
Tenure
Since
ALA
ALA
Arovella Therapeutics Limited
  • Non-Executive Director
  • Non-Executive Chairman
5mthApr 2026
RMY
RMY
RMA Global Limited
  • Non-Executive Director
9yrs, 10mthNov 2016

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
RMY
RMY
RMA Global Limited
20/10/26N/A208,002,5044,517,055N/A
ALA
ALA
Arovella Therapeutics Limited
30/06/26N/A200,000N/AN/A
PNV
PNV
26/09/25N/A21,655,0000N/A
IIQ
IIQ
30/06/25N/A5,179,33790,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
RMY
RMY
RMA Global Limited
20/10/26
Buy
522,224$0.017$8,877On-market trade
RMY
RMY
RMA Global Limited
19/10/26
Buy
500,000$0.018$9,000On-market trade
RMY
RMY
RMA Global Limited
16/10/26
Buy
500,000$0.018$9,000On-market trade
RMY
RMY
RMA Global Limited
13/10/26
Buy
21,047$0.018$378On-market trade
RMY
RMY
RMA Global Limited
12/10/26
Buy
978,953$0.019$18,620On-market trade